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PENILAIAN PROJEK SARINGAN KANSER KOLOREKTAL 
MENGGUNAKAN ALAT PENGESAN DARAH SAMAR DALAM NAJIS 
(PDSN) DI PULAU PINANG, MALAYSIA 
 
ABSTRAK 
Insidens kanser kolorektal (KKR) semakin meningkat di negara-negara membangun 
disebabkan oleh perubahan gaya hidup. Di Malaysia, KKR berada pada tahap kedua 
daripada semua jenis kanser dengan insidens tertinggi berlaku dalam kalangan kaum 
Cina. Saringan berkala untuk KKR menggunakan alat pengesan darah samar dalam 
najis (PDSN) telah diketahui dapat menurunkan kejadian kematian dan kesakitan 
akibat gejala penyakit ini. Tujuan kajian ini adalah untuk menilai suatu program 
saringan kanser KKR menggunakan alat PDSN di Pulau Pinang, Malaysia. Sebanyak 
970 alat PDSN telah diedarkan antara bulan Jun hingga November 2009 semasa 
ceramah kesihatan mengenai KKR diselenggarakan. Data dikumpulkan melalui 
borang soal selidik yang diisi sendiri oleh peserta dan temu bual melalui telefon. 
Semua analisis dilakukan menggunakan perisian analisis ramalan (PAR) versi 18 
untuk statistik deskriptif dan juga analisis regresi logistik binari untuk mengetahui 
faktor-faktor yang berkaitan dengan pengetahuan mengenai KKR dan keperluan 
mengembalikan semula alat PDSN. Seramai 617 orang peserta telah melengkapkan 
borang soal selidik (63.6%). Hanya sedikit peserta (3.8 %) yang menyatakan mereka 
menghadapi kesukaran untuk menjalani ujian ini. Tahap kesedaran peserta mengenai 
ujian najis dan pengetahuan mengenai KKR didapati rendah. Faktor yang berkaitan 
dengan rendahnya tahap pengetahuan peserta mengenai KKR ini ialah pendidikan 
yang rendah (OR = 3.07; 95%CI: 2.01-4.70) dan tiadanya sejarah keluarga yang 
menghidap kanser (OR = 1.71; 95%CI: 1.16-2.52). Kelompok umur yang lanjut (OR 
 xii 
= 3.31; 95%CI: 2.09-5.23), etnik Cina (OR = 2.35; 95%CI: 1.32-4.19), dan 
pendidikan yang lebih tinggi (OR = 2.26; 95%CI: 1.49-3.42) merupakan faktor yang 
berkaitan dengan pengembalian alat PDSN. Tiga puluh satu orang peserta mendapat 
hasil positif dan beberapa peserta merasa cemas (30%) dan takut (25%) selepas 
mengetahui hasil ujian. Lapan peserta menjalani  kolonoskopi. Satu kes KKR 
disahkan dijumpai pada seorang peserta wanita berketurunan Cina berumur 61 tahun 
; dua orang peserta menghidapi polip ; seorang peserta menghidapi kolitis berulser 
dan seorang lagi peserta menghidapi  buasir. Sembilan perserta yang tidak menjalani 
kolonoskopi diwawancara dan 6 orang menyatakan bahawa mereka telah berjumpa 
dengan doktor tetapi doktor tidak mencadangkan mereka untuk menjalani 
kolonoskopi dan tiga orang peserta lainnya tidak menjumpai sebarang doktor. 
Sebagai kesimpulan, kajian ini menemukan kadar pengembalian PDSN sebesar 
56.7% dan hanya seperempat peserta dengan KKR positif menjalani kolonoskopi. 
Meskipun projek saringan KKR ini menemukan satu pesakit menghidapi KKR, 
adalah disyorkan untuk mengambil langkah-langkah untuk meningkatkan kepatuhan 
dalam pengembalian alat PDSN dan menjalani kolonoskopi selepas mendapati hasil 
ujian positif. 
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ASSESSMENT OF A COLORECTAL CANCER SCREENING PROJECT 
USING FAECAL OCCULT BLOOD TEST (FOBT) KIT 
IN PENANG STATE, MALAYSIA 
 
ABSTRACT 
 
Incidence of colorectal cancer (CRC) has been increasing in many countries due to 
changes in life style. In Malaysia, CRC is the second most common cancer with the 
highest incidence among the Chinese ethnic group. Periodic screening for CRC with 
faecal occult blood test kit (FOBT) has been shown to reduce the mortality and 
morbidity from this disease.  The objective of this study was to assess a CRC 
screening project using FOBT kit in Penang, Malaysia. A total of 970 FOBT kits 
were distributed between June and November 2009 during CRC public health talks. 
Data was collected using self-administered questionnaires and telephone interviews. 
Statistical analyses were carried out using PASW version 18 for descriptive statistics 
as well as for the binary logistic regression analyses to determine associated factors 
for CRC knowledge and return of FOBT. A total of 617 participants completed the 
first questionnaire with a response rate of 63.6 %.  Few (3.8 %) reported 
encountering difficulties in doing the FOBT. The level of awareness of stool 
examination and knowledge of CRC were poor among participants. The factors 
associated with poor knowledge of CRC were low education (OR=3.07; 95%CI: 
2.01-4.70) and not having family history of cancer (OR=1.71; 95%CI: 1.16-2.52). 
Older age (OR =3.31; 95%CI: 2.09-5.23), Chinese ethnicity (OR=2.35; 95%CI: 1.32-
4.19) and higher education  (OR=2.26; 95%CI:1.49- 3.42) were factors associated 
with the return of FOBT kit. Thirty-one participants had positive FOBT result and 
 xiv 
some reported feeling anxious (30%) and frightened (25%) after knowing the result.  
Eight participants underwent colonoscopy. One case of CRC was found in a 61 year 
old Chinese female; two participants had polyps; one participant with ulcerative 
colitis and another with haemorrhoids. From the 9 participants who did not undergo 
colonoscopy, 6 reported seeing doctors for follow-up but were not advised 
colonoscopy and 3 did not seek any medical advice for the positive FOBT. In 
conclusion, this study found a return rate for FOBT of 56.7% and only a quarter of 
the positive FOBT cases underwent colonoscopy. Although the CRC screening 
project identified one case of CRC, it is recommended that steps be taken to increase 
the compliance in FOBT return and colonoscopy following a positive FOBT.  
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CHAPTER 1 
INTRODUCTION 
1.1  Background of the Study 
 Colorectal cancer (CRC) is now a major concern for many developed and 
developing countries. In the past, most cases of this cancer were found in developed 
countries and was considered a disease of western life style (World Health Sciences, 
2010). In recent years, the incidence of CRC has been increasing in the developing 
countries, due to changes in life style, which include a more sedentary life style, 
obesity, alcohol intake and smoking habit (World Health Organization, 2007). 
According to the National Cancer Registry Report 2011, CRC was the second 
most common cancer among males and females in Malaysia in 2007. There were 
2,246 CRC cases or 12.3% of all cancer cases. The age standardized rate (ASR) for 
males was 13.4 per 100,000 population, while for females it was 10.2 per 100,000 
population. The highest ASR was found among the Chinese ethnic group, with 19.4 
per 100,000 population for males, and 14.6 per 100,000 population for females. 
Among Indian males, the ASR was 10.2 per 100,000 population; among Malay 
males, 10.1 per 100,000 ; among Malay females, 7.6 per 100,000 population; and the 
lowest ASR was among Indian females, 6.9 per 100,000 population (Omar, 2011).  
This data showed that the Chinese had the highest risk of being diagnosed 
with CRC compared with other ethnic groups in Malaysia (Ministry of Health, 
2009). Therefore, it is important to have a CRC screening programme in Malaysia 
especially among the Chinese ethnic group. Moreover, a CRC screening programme 
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has never been done before in Malaysia. Therefore, this study provides the first 
opportunity to screen the community for CRC. 
Penang state has a population of 1.5 million, with a population breakdown 
showing a  majority of Chinese ethnic group  (46.5%), followed by Malays (42.1%), 
Indian and others (0.8 %). The number of cancer cases in Penang for the years 1999 
to 2003 was 7,553 cases, of which 3,514 cases were males and 4,039 cases were 
females (Bina Rai, 2005). The CRC cases occurring in Penang state during that same 
time interval was 839 cases, with 458 males and 381 cases were females. From the 
458 male cases, the highest number of cases were of Chinese ethinicity with 348 
cases (76%), and from the 381 female cases, 284 cases (74.5%) were also among the 
Chinese (Bina Rai, 2005).  
With a population that has a majority of Chinese ethnic group, Penang is 
somewhat similar to Singapore (Singstat, 2010). Based on the Singapore experience 
of CRC screening programme done in 2008, it could be expected that if 1000 FOBT 
kits are made available, at least one case of CRC would be identified (Singapore 
Cancer Society, 2009). Therefore, this study aimed to assess a CRC screening project 
in Penang state, to detect CRC cases or precancerous lesions (polyps) at an early 
stage. The benchmark for the success of the programme was set at finding at least 
one CRC case.   
Many CRC screening programmes have been conducted in several other 
countries and only results of FOBT test, showing the number of positive and 
negative result are reported (Singapore Cancer Society, 2009-2011; Chew, 2009;  Fu, 
2009; Logan, 2012; Chong, 2013; Al Ahwal, 2013). There is still information which 
has not been described yet, for example, the feed back from participants regarding 
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the stool examination, reasons of noncompliance to FOBT and colonoscopy, 
knowledge of CRC and awareness of stool examination. Such information can be 
useful for the healthcare  planners to formulate a screening programme. Therefore, it 
is timely to carry out this study to assess a community-based CRC screening project. 
1.2  Objectives of the Study 
The objectives of this study are as follows: 
1. To assess a CRC screening project using FOBT kit by determining the return 
rate of FOBT kit and compliance rate for colonoscopy among participant with 
FOBT (+).   
2. To assess the knowledge of CRC and awareness of stool examination and the  
            associations with the demographic factors and to assess the  usage of FOBT  
            kit among participants.  
3. To describe reasons for noncompliance for the FOBT and colonoscopy. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1  Colorectal Cancer 
Cancer or a malignant tumour refers to an abnormal and uncoordinated 
growth with proliferation of cells that can invade and destroy the tissue surrounding 
it and spread to other organs and cause death (Kumar, 2007). 
Colorectal cancer (CRC) is cancer originating from cells of the colon and 
rectum. Most of the cancers are of the adenocarcinoma type (98%), with most 
precursor lesions originating from adenomas. Majority of CRC cases have occured 
among males compared to females (Kumar, 2007). 
Most adenomas appear in the colon or rectum by the age of 50 years, and 
develop into cancer within 5 to 10 years (Rozen, 2006).  
CRC is a treatable and curable cancer if it is detected at an early stage. 
Routine CRC screening will increase the detection rate of precancerous adenomas as 
well as CRC. Removing precancerous adenoma will reduce future incidence of CRC 
(Rozen, 2006). 
2.2  Epidemiology  
In the USA, CRC was responsible for 15% of the total number of cancer 
deaths and was the second most common cause of death among all cancer cases 
(Winawer, 2007).  Every year at least 1 million people in USA are diagnosed with 
CRC. A total of 1,023,000 cases were found in USA in 2007, about 550,000 among 
males and 473,000 among females. The number of deaths was 278,000 males and 
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255,000 females (Winawer, 2007). It has been estimated that every person has a 5% 
chance of getting this disease (Kumar, 2007), and the highest incidence of CRC was 
among African Americans (Jandorf, 2005). From Surveillance Epidemiology and 
End Result (SEER) data for 1973-1989, the ASR for CRC among African American 
males was calculated to be 39% and among white American males was 11%. The 
ASR for the African American females was 26% and among white American 
females was 3%. In 1990, the ASR in USA reduced because of the successful 
prevention programme through polypectomy (Winawer, 2007). 
In the United Kingdom, CRC was the third most common cancer occurring in 
both males (after lung and prostate cancer) and females (after breast and lung 
cancer). The incidence was found to be higher among males than among females. 
Every year, about 32,000 new CRC cases are diagnosed, especially arising in the 
rectum and sigmoid region (Garden, 2007). In Eastern and Southern Europe, the 
ASR has increased, but in the areas of North and Central Europe, it has levelled off 
(Winawer, 2007). 
Other countries that have reported a high incidence of CRC were Canada, 
Australia, New Zealand, Denmark, and Sweden. In Australia, CRC was the second 
most common cause of death among all cancer cases. The risk for getting this disease 
was reported as 1:17 for males and 1:26 among females (Australia, 2004).  
CRC also becomes the third most common cancer cases among males and 
females in Asia (Pourhoseingholi, 2012). Some Asian countries reported high 
incidence of CRC such as Japan, Singapore, South Korea, Taiwan, Hong Kong, and 
Iran (Kumar, 2007; Pourhoseingholi, 2012). In Japan, the incidence of CRC in 
people under the age of 50 years was very low, but it increased dramatically among 
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the population aged 50 years and older (Winawer, 2007). Incidence of CRC has 
increased two- to four-fold in recent decades in Singapore, China, Japan and South 
Korea (Pourhoseingholi, 2012). Incidence of CRC is higher among the Chinese 
compared to other ethnic groups in Asia, likewise to Chinese people who live in 
Malaysia (Pourhoseingholi, 2012). Furthermore, the incidence of CRC in Asia 
Pacific countries is now comparable to the incidence of CRC in western countries 
such as United States, Canada and European countries (Wong, 2011). 
The incidence of CRC has also increased in the last decade in Malaysia (Bina 
Rai, 2005). Ten years ago, CRC was the third most common cancer among males 
and females in Malaysia, but  it is now the second most common cancer  (Bina Rai, 
2005). Moreover, malignant neoplasm has become the third most common cause of 
death in the government hospitals in Malaysia after septicaemia and heart and 
pulmonary diseases (Ministry of Health, 2009). 
2.3  Aetiology and Risk Factors 
The cause of CRC is unknown (Allison, 2007). There is a complex 
relationship between environmental and genetic risk factors that contribute to the 
development of CRC. Age is one risk factor, as the incidence of CRC increases after 
the age of 50 years. Other risk factors found in many countries include diets with a 
high proportion of animal meat which have been cooked at high temperatures, a low 
portion of vegetables or fruits, and high consumption of alcohol. Gender, obesity, 
lack of exercise, smoking habits, diabetes, inflammatory bowel diseases such as 
ulcerative colitis and Crohn’s disease, adenomatous polyps, and cancer in other 
organs also have been implicated as risk factors (Rozen, 2006). 
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A person with a family history of CRC has a higher risk of getting the 
disease, compared with one with no family history (Rozen, 2006). This risk has been 
estimated as being two times higher than that of a person with a negative family 
history (American Cancer Society, 2008). The genetic factors which have been found 
to be important in CRC are Lynch syndrome (hereditary nonpolyposis colorectal 
cancer), familial adenomatous polyposis, familial juvenile polyposis, and Peutz-
Jeghers syndrome (Rozen, 2006). 
2.4  Diagnosis   
Diagnosis of CRC is based on the signs and symptoms, laboratory, radiology, 
and endoscopic examination. The history taken from the patient should include 
questions on risk factors and past medical history such as ulcerative colitis and 
haemorrhoids to identify possible causes of blood in the stool.  
2.4.1  Signs and Symptoms   
The symptoms and clinical signs of CRC depend on the location of the 
tumour in the colon or rectum, and the presence of spread. If the tumour is in the 
right side of the colon, the patient usually complains of abdominal pain, or a feeling 
of a mass in the abdomen, or both. If the tumour is in the left side of colon, the 
patient commonly complains of abdominal pain, melaena, or fresh bleeding from 
rectum, and constipation. If the tumour is in the area of the rectosigmoid or rectum, 
patients usually experience melaena from rectum, constipation, tenesmus, and the 
diameter of the stool becomes smaller (Rozen, 2006). There may be a past medical 
history of ulcerative colitis, Crohn’s disease, polyps, haemorrhoids, diabetes 
mellitus, as these are all risk factors for this cancer. 
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On physical examination in the case of an advanced stage of CRC, one may 
find signs of anaemia, weight loss, an enlarged liver, a mass in abdomen, especially 
if the cancer developed on the right side. There can be signs of intestinal obstruction, 
ascites, and symptoms of parietal pain if there is invasion to the wall of the abdomen, 
perianal pain or sciatic pain in the late stage of rectum cancer (Garden, 2007). 
A patient with CRC may present with a history and physical examination 
similar to appendicitis or diverticulitis or even chronic perforation which produces 
symptoms of recurrent urinary tract infection and haematuria. There may also be 
signs of Peutz-Jeghers syndrome (hyperpigmentation of skin and mucous 
membranes). 
Malignancies in the gastrointestinal tract have been  known to produce 
symptoms of paraneoplastic phenomenon, for example, acanthosis nigricans, 
dermatomyositis, and hypercalcemia, but these are usually manifestations of CRC in 
its late stage (Berg, 2001).  
2.4.2  Laboratory Examination  
FOBT kit is used to detect blood in the stool. It has high sensitivity and 
specificity, 92% and 96% respectively in detecting CRC (Van Rossum, 2008; Park, 
2010), but further examinations are needed to confirm if the positive FOBT is due to 
CRC (Berg, 2001).  
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2.4.3  Radiological Examination  
Radiological examinations are used as diagnostic tools to detect CRC and 
metastases to other organs. Each type of radiological examination has its advantages 
and disadvantages when implemented in a screening programme.   
2.4.3.1  Plain X-ray 
Plain x-ray of abdomen can be carried out quickly, but it would not be a 
satisfactory screening modality as by the time a colorectal mass is visible on x-ray, it 
is already at a late stage and may have already produced symptoms. Furthermore, the 
disadvantages of x-ray examinations are  radiation exposure and the need for bowel 
preparation before any abdominal radiological examination.  
A plain x-ray of the chest can identify the presence of metastases to the lung. 
About 10% of patients with cancer of the rectum have metastases to the lungs at the 
time of diagnosis (Berg, 2001).  
2.4.3.2  Barium Enema  
A double contrast barium enema is widely available in many places 
(Winawer, 2007). This examination can detect 90% cases of CRC and 80% of polyps 
with diameter more than 1 cm, but it is less sensitive for polyps with diameter less 
than 1 cm (Rozen, 2006). This examination needs to be repeated every five years if 
polyps are not found (Cleveland, 2010). Barium enema can help in diagnosis, but it 
cannot facilitate a biopsy or polypectomy and it requires good bowel preparation 
(Berg, 2001).   
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2.4.3.3  Computed Tomography (CT) Scanning   
Computed tomography scanning can be used to detect the spread of CRC to 
other organs, especially to the lung, liver, abdomen, chest, and pelvis. However, a 
contrast agent needs to be inserted to the vein before scanning, which makes this 
examination an invasive procedure (Berg, 2001). Exposure to radiation is higher than 
in a regular x-ray, while some patients have experienced an allergic reaction to the 
contrast agent (National Cancer Institute, 2012). This scanning is more useful for 
staging CRC rather than for a screening modality. 
2.4.3.4  Computed Tomography (CT) Colonography  
CT colonoscopy is also known as virtual colonoscopy, virtual endoscopy, or 
3D-endoscopy. It can show a three dimensional figure by using multislice x-ray 
technology. This examination is less invasive compared with colonoscopy, and the 
patient does not need sedation. The disadvantage of this procedure is that a 
colonoscopy is still needed if polyps are found in the colon for polypectomy. The 
patient still needs colon cleansing before examination (Berg, 2001). 
The sensitivity of this examination has been reported as between 45% and 
97%, and the specificity is between 26% and 97% depending on the size of polyps. 
The examination is not satisfactory for polyps with the size 6 to 9 mm. The 
sensitivity and specificity increase to 93% and 97% for larger polyps with diameter 
of 10 mm or more (Winawer, 2007). Patients who undergo this examination will be 
exposed to ionizing radiation repeatedly, and the cost for this examination is 
expensive (Winawer, 2007).   
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2.4.3.5  Magnetic Resonance Imaging (MRI)  
This examination (MRI) is usually carried out to detect relapse of CRC or if 
the liver has not been visualized adequately by CT scan. The advantages of MRI over 
a CT scan include the use of noniodine contrast agent to get clearer images and the 
lack of radiation exposure. The disadvantage of MRI is that it is an expensive 
procedure. In many countries, facilities for conducting MRI are limited. Furthermore, 
MRI cannot be used when patients have pacemakers or any metallic implants, 
therefore, this examination is not suitable for population screening (Rozen, 2006). 
2.4.4  Endoscopic Examination  
Endoscopic examination is an appropriate examination for detecting CRC, 
when applied in a CRC screening programme. To get maximum advantage and 
minimum disadvantage for patients, certain conditions and criteria have to be 
fulfilled, as will be described in the following subsections. 
2.4.4.1  Rigid Proctosigmoidoscopy 
This examination has been reported as capable of detecting between 25% and 
30% of CRC cases. The advantage of this examination is that it does not need 
sedation or colon cleansing preparation, and is an outpatient procedure. One 
disadvantage of rigid sigmoidoscopy is that it only has an endoscope length of 20 
cm, therefore it is only able to reach the rectosigmoid junction of the colon. The rest 
of the colon where 70% to 75% of CRC may develop, cannot be visualized. Proper 
training is also required to perform this examination (Rozen, 2006).  
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2.4.4.2  Flexible Sigmoidoscopy   
The lengths of flexible endoscopes are 30 cm and 60 cm, and visualization of  
the sigmoid and descending colon  is possible. About half to two-thirds of CRC cases 
can be detected by this examination. The examination can be carried out without 
sedation but requires bowel preparation (Rozen, 2006). 
Complications including perforation can occur at a rate of 1:10,000. 
However, reports have shown that flexible sigmoidoscopy can reduce the mortality 
of colorectal cancer by 60% to 70% (Winawer, 2007).  
The disadvantages of this examination are that it cannot reach the ascending 
and transverse colon, and thus CRC arising in those areas can be missed. Bowel 
preparation using enema is still needed. Furthermore, the examiner needs sufficient 
training to perform this examination (Rozen, 2006).  
2.4.4.3  Colonoscopy   
Colonoscopy can visualize the whole colon. It can be used as a diagnostic 
tool, for example, when doing a biopsy. It can also be used as a therapeutic tool 
because resection of the polyps (polypectomy) can be carried out. Colonoscopy can 
also detect small polyps with diameter less than 10 mm.  
The sensitivity and specificity of colonoscopy has been reported as 95% in 
detecting polyps and CRC. The miss rate of colonoscopy for polyps is about 15% to 
25% for adenomas with diameter less than 5 mm, and 0% to 6% for adenomas equal 
to 10 mm or bigger (Winawer, 2007). 
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Finding polyps by colonoscopy can help reduce the mortality of CRC by 60% 
to 80% and periodic colonoscopy with polypectomy has been estimated as being able 
to prevent 76% to 90% of cases of CRC (Benuzillo, 2009). 
Colonoscopy is considered to be the gold standard examination in United 
States, after FOBT positive was found (Winawer, 2007). 
The disadvantages of colonoscopy include the need for sedation and colon 
cleansing preparations. A highly skilled operator is needed to perform the 
examination, and the cost is expensive (Rozen, 2006).  
The complication rate of colonoscopy is reported to be 1 to 2 among 1000 
examinations, the complications that occur include severe haemorrhage and bowel 
perforation (Winawer, 2007). 
2.5  Prevention of CRC 
Prevention of CRC starts with the education of people regarding the 
importance of good diet and healthy lifestyles. The recommended good diet is to 
include more fibres, vegetables, fruits, fish, and low-calorie milk with sufficient daily 
supplements of calcium, iron, and folic acid. A healthy  life style will include doing 
regular exercise, abstaining from smoking, reducing alcohol consumption, preventing 
obesity, and changing the pattern of cooking meat and fish by minimizing cooking 
with  high temperature or by roasting with charcoal (Rozen, 2006).  
A healthy man with genetic hereditary conditions such as Familial 
Adenomatous Polyposis (FAP) and Hereditary non-Polyposis Colorectal Cancer 
(HNPCC) or Lynch syndrome should undergo  screening regularly from an early age. 
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For people with FAP, they need to have an annual sigmoidoscopy programme, and it 
should be started from the age of 10 to 12 years old.  For  people with HNPCC,  
colonoscopy examination has to be initiated 10 years earlier than the age of the 
youngest family member that had CRC (Winawer, 2007).  
In Malaysia, some programmes have been implemented for cancer 
prevention, such as breast self-examination and mammography to detect breast 
cancer in early stage, hepatitis B immunization for babies, papanicolaou’s smear and 
human papilloma virus (HPV) immunization for Malaysian girls aged 13 years old 
and above against cervical cancer, and anti-smoking campaign (Lim, 2002; Ministry 
of Health, 2009; Norbaya, 2010).  
Ministry of Health Malaysia has launched The Non-Communicable Diseases 
Prevention 1Malaysia (NCDP-1M) programme in 2010 to detect individuals with 
non-communicable disease risk factors at an early stage (Omar, 2012). A National 
Cancer Registry (NCR) has been established in 2006 to collect data about cancers in 
Malaysia. The NCR facilitates in providing information regarding overall cancer 
incidence in Malaysia, which is useful for planning and evaluation for cancer 
prevention and control (Omar, 2012). A number of healthy lifestyles campaigns have 
been launched such as ‘walking a 10,000 steps’ and ‘senam tari’ activities (Omar, 
2012). Collaboration between public, private sectors and non-governmental 
organizations in cancer prevention has been established (Lim, 2002) and some non-
governmental organizations in Malaysia, such as National Cancer Society of 
Malaysia (NCSM), National Cancer Council (NCC) have been giving public 
education on CRC such as health talks and seminar, counseling for the patients and 
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their families. These programmes are implemented to reduce the burden of cancer in 
Malaysia in the future (Lim, 2012).  
2.6  Screening of CRC  
Screening is a process to detect a certain disease among healthy or 
asymptomatic people in the community (Rozen, 2006). CRC screening is very 
important, as CRC is known to be a curable cancer if it is found at an early stage. 
Furthermore, if polyps are detected and removed, it can reduce the incidence of 
having cancer in future. Therefore, screening is very useful to reduce the mortality 
and morbidity of CRC. 
In some countries, CRC screening has been carried out routinely, but each 
country has a different method of screening. The choice of screening method 
depends on the resources, such as the financial support, the availability of health care 
services, and the number of trained professional health workers.  
The success of any screening programme depends on several factors. These 
factors include awareness of the patient, approval from primary care clinic doctors, 
acceptance of participants, adequate funds, accurate risk group classification, 
sensitivity and specificity of the screening test, diagnosis and treatment in 
appropriate time, and  appropriate follow-up (Winawer, 2007). 
The Asia Pacific Working Group for CRC had formulated consensus 
regarding  CRC screening for Asian countries in 2008. They stated that CRC 
sceening should be a national health priority due to the rapid increase of CRC cases 
in Asian countries, such as China, Japan, Korea, Hong Kong, Singapore and 
Malaysia (Sung, 2008).  
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In resource-limited countries, FOBT is recommended to be the first choice for 
CRC screening. A study by Lee et al. in Japan showed using immunochemical FOBT 
(IFOBT) decreased CRC mortality by 70% (Lee, 2007).  
In 2008, Singapore conducted a CRC screening programme using IFOBT 
with a good response (Singapore Cancer Society, 2009). The Singapore Cancer 
Society carried out the programme and distributed 22,510 FOBT kits to the 
community. Free FOBT kits were distributed with each participant receiving 2 kits. 
The result would be considered a positive FOBT if either one of the sample was 
positive for occult blood. Participants with FOBT positive would undergo 
colonoscopy examination. Participants with FOBT negative were advised to repeat 
the FOBT examination annually. The FOBT kit used was the OC-Light 
Immunochemical FOBT, which was the same kit used in this study.   
The screening programme in Singapore detected 32 cases of CRC and 
removed polyps from 128 patients, of which 91 were precancerous polyps. Singapore 
Cancer Society declared that the CRC screening programme in 2008 was successful 
and effective, and has saved the lives of 123 people (Lau, 2009).   
2.6.1  CRC Screening in Malaysia 
 The Ministry of Health Malaysia has reported an increase in CRC incidence 
in Malaysia. The ASR was 8.1 per 100,000 population in 1987; 11.9 in 1998; 13.9 in 
2002; and  18.4 in 2006 in Peninsular Malaysia (Azlie, 2011), but there has been no 
CRC screening implemented in Malaysia at national level. In August 2010, the 
Ministry of Health Malaysia conducted a CRC screening project in Negeri Sembilan, 
Malaysia and screened 310 people using IFOBT (Omar, 2012).  In 2013, another 
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CRC screening project was carried out in Kedah state, Malaysia which targeted 
asymptomatic male and female populations, aged 50 years old and above (Radzi, 
2013). According to the Clincal Practice Guidelines (CPG) for CRC screening in 
Malaysia 2001, the type of FOBT recommended for screening is Hemoccult II 
(SmithKline Diagnostic Inc., San Jose, CA) and colonoscopy is to be used for high 
risk individual (Qureshi, 2001). However, the Malaysian Health Technology 
Assessment Section (MAHTAS), under Medical Development Division Ministry of 
Health Malaysia has recommended the use of immunochemical FOBT (IFOBT) for 
CRC screening for general population in Malaysia (Azlie, 2011). As this study was 
carried out in 2009, one could consider this study as initiating the use of IFOBT in 
Malaysia. 
2.7  Awareness of Stool Examination and Knowledge of CRC  
 Not many studies report on the  awareness of stool examination and 
knowledge of CRC, especially in Malaysia. The majority of researchers did not 
report on the awareness of stool examination,  knowledge of CRC or feedback 
regarding the use of FOBT. A study conducted by Harmy et al. among moderate risk 
patients in West Malaysia showed that the majority of patients had low knowledge 
and attitude towards CRC screening (Harmy, 2011). A study carried out by 
Bobryshev  et al. among 300 university students in Malaysia showed the majority of 
the participants had no knowledge about faecal occult blood screening and 
colonoscopy (Bobryshev, 2013). Another study by Nahas et al. among university 
students in Penang reported that the majority of students had a lack of knowledge of 
CRC and dietary habits related to CRC (Nahas, 2013). A CRC screening project 
carried out by Chong et al. among 153 participants in Kuala Lumpur did not carry 
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out an assessment on the awareness of stool examination or knowledge of CRC 
(Chong, 2013).   
Some studies from other countries had done assessment regarding knowledge 
of CRC. One example is a study by Wong, et al. in China which stated that high risk 
participants (male and smokers) had poor knowledge of CRC (Wong, 2013). Another 
study  in Turkey carried out by Kaya et al. among 100 auxiliary healthcare personnel 
found some knowledge deficiency  regarding early diagnosis, screening of CRC and 
potential causes of CRC among  their participants (Kaya, 2013). This study would 
assess a CRC screening programme as well as the knowledge of CRC and awareness 
of stool examination in Malaysia for the first time. 
2.8  FOBT Kit 
FOBT kit is a kit to detect occult blood in human stool. Under normal 
conditions there should be no blood in the stool. Blood in stool can be caused by 
several conditions such as inflammatory bowel diseases, haemorrhoids, polyps, as 
well as cancer in the gastrointestinal tract. Further examinations such as 
colonoscopy, sigmoidoscopy, and barium enema are needed to confirm the diagnosis 
of those diseases and rule out cancer.  
Two types of FOBT kits are available, a chemical FOBT (CFOBT) and an 
immunochemical FOBT (IFOBT) or  FIT.  
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2.8.1  Chemical FOBT  
The chemical FOBT  is also called the Guaiac Test, as it uses guaiac acid. In 
principle, the examination detects the activity of peroxidase in haeme and guaiac will 
be oxidized and become blue. If a colour change occurs, then the result is positive, 
and this is an indication that bleeding has occured in the colon or rectum (Allison , 
2007). 
Some examples of guaiac kit test are Hemoccult II (Beckam Coulter Inc., 
Primary Care Diagnostic, LA, CA, USA); Hemoccult Sensa, Hema-screen 
(Immunostics, Ocean, NJ). However, Hemoccult II and Hemoccult Sensa have some 
disadvantages. Hemoccult II has low sensitivity and Hemoccult Sensa has low 
specificity in detecting cancer and significant polyps (>1cm). The low sensitivity will 
limit the effectiveness in reducing the mortality rate of CRC, and low specificity will 
increase the cost of screening by colonoscopy and the inconvenience for the patients 
who have to undergo the procedures (Allison, 2007). 
False positive results can occur because haem is also found in red meat, 
peroxidase activity can also be found in fresh fruits and vegetables, such as broccoli 
and white radish. Vitamin C can also affect the result, because it can inhibit the 
reaction of guaiac. Therefore a test using guaiac needs restriction of certain foods 
prior to conducting the examination (Allison, 2007). This can lead to a low 
participation in screening programme and this has been shown in a study conducted 
in Australia on motivated volunteers who were asked  to restrict certain foods before 
the test. Because of this restriction the number participation dropped by 13%, 
because in Autralia, red meat is a large part of the people’s normal diet (Allison, 
2007). 
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Moreover, stool samples for the guaiac test have to be in a dry state and must 
be smeared onto the kit impregnated paper with the wooden stick. This could also 
reduce the acceptance of the participants to do the test (Allison, 2007), hence these 
are the reasons why chemical FOBT was not used in this study, because it has many 
limitations, and currently chemical FOBT has been replaced in some countries by 
immunochemical FOBT because it has more advantages (Winawer, 2007). 
2.8.2  Immunochemical FOBT   
Immunochemical FOBT (IFOBT) or FIT is a new type of FOBT kit. Some 
examples of IFOBT that have been used for large number of people in the average 
risk group are FlexSure OBT, HemeSelect, Insure, MagStream 1000/Hem SP (Fuji 
Rebio Inc, Tokyo, Japan). Other examples are Hemoccult-ICT, Instant View, 
ImmoCare, MonoHaem, Clearview Ultra-FOB, OC Auto Micro 80, and Magstream 
Hem Sp ( Allison, 2007).   
The most commonly used IFOBT in the USA is Insure (Enterix Corporation, 
Falmouth, Maine). It has been approved by U.S. Food and Drug Administration 
(FDA) because it has higher sensitivity and specificity compared with guaiac FOBT 
or other immunochemical FOBT kits (Allison, 2003). IFOBT used in Japan is 
ImmudiaHem Sp (Fujirebio Inc, Tokyo). In the UK, IFOBT used is HemeSelect and 
FlexSure OBT from Smith Kline Diagnostic, San Jose, California (Allison, 2003).  
In Malaysia, OC-Light IFOBT is available and distributed by Nagase Shd 
Bhd in Kuala-Lumpur. It is imported from Eiken company, Japan (Nagase, 2009a). 
This IFOBT  had been used for this study, because of its benefits compared to guaiac 
test. Other IFOBTs available in Malaysia are VEDA LAB Hem Check-1 (France), 
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Chemtrue One-Step FOBT Test (China),  and ACON FOB One Step Faecal Occult 
Blood (USA) (Azlie, 2011).  
IFOBT was used in this study, because IFOBT are superior compared to 
guaiac FOBT. IFOBT uses specific monoclonal and polyclonal antibodies to detect 
human haemoglobin in the stool. These antibodies are labelled and these antibodies  
react with antigens of globin in the stool, a positive result will be produced (Allison, 
2007). 
IFOBT is more specific for detecting globin originating from the large bowel, 
because globin cannot survive the passage through the upper gastrointestinal tract 
(Allison, 2007). 
Furthermore, IFOBT does not react with globin that is not of human origin, 
for example from meat, uncooked vegetables, or fruits that might contain peroxidase 
activity. Hence a restricted diet before the test is not needed (Allison, 2007). 
IFOBT is not affected by drugs such as nonsteroid anti-inflammatory drugs 
(NSAID), and vitamin C. The procedure for sample collection is relatively simple 
compared with the guaiac test. IFOBT can be analysed by  a  machine provided by 
the manufacturer of the FOBT kit and the interpreter does not need special training to 
perform it. In 2004, USA Centre for Medicare and Medicaid Services (CMS) stated 
that IFOBT is a suitable and effective kit for CRC screening programmes. Its 
utilization to a huge population, can be adjusted according to the ability of the 
government or screening promoter to provide the budget and the human resources. In 
addition, it can achieve a good result (Allison, 2007). 
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The use of colonoscopy as a first line screening tool in the USA is inadequate, 
therefore, IFOBT has been recommended as the first line screening modality in the 
USA (Allison, 2007).   
Malaysian Health Technology Assessment Section (MAHTAS), under 
Medical Development Section, Ministry of Health Malaysia has assessed accuracy, 
safety and efficacy of IFOBT and they have reported that IFOBT can be considered 
for  CRC screening among general population in Malaysia (Azlie, 2011), hence 
IFOBT was chosen for this study.  
2.9  National Cancer Society Malaysia, Penang Branch 
National Cancer Society of Malaysia (NCSM) Penang Branch is a nonprofit, 
non-governmental organization. It is a branch of NCSM Kuala Lumpur, that was 
established in 1968 (National Cancer Society of Malaysia, 2010).  
The organization has the following vision,   
... to help reduce the cancer burden of the country through: 
dissemination of information on cancer, cancer prevention, early 
detection of cancer through screening, patient support, and 
supporting Penang based cancer register  (National Cancer Society 
of Malaysia, 2010). 
 
 
Since its inception in 1968, NCSM Penang branch has launched many 
activities related to combating cancer. The NCSM has organized activities such as 
screening of the cervical cancer, seminars, talks, courses, conferences about cancer, 
and so on. In 1989, the society launched a mammography centre and offered 
screening mammograms to the public for a small fee. In 1992, the society launched a 
“Hospice at Home Programme”, and since 1995, the society has given cancer 
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education to the students in many schools in Penang.  NCSM managed Rumah 
Hospice Penang from 2001 until 2009. In 2005, NCSM received the franchise of 
“Relay for Life” from American Cancer Society and has organized fund-raising 
events annually in Penang. The funds raised from the public have been used to 
finance the activities carried out by the society. In 2009, the society conducted CRC 
health talks in several senior citizen organizations in Penang state and  assisted  in 
the distribution and collection of the FOBT kits from the participant and sending the 
FOBT kits to the laboratory (National Cancer Society of Malaysia, 2010).  
2.10  Conceptual framework  
 Screening for CRC was assessed in this study. The  success of the screening 
would be influenced by the compliance of the participants to the FOBT testing. The 
higher the number of returned FOBT kits would imply good compliance to FOBT 
testing and a low number of returned FOBT kits showed low compliance to FOBT 
testing. Some factors that influence the  compliance to FOBT testing will be 
explored. Participants with FOBT positive were encouraged to undergo colonoscopy 
examination and   the compliance rate to colonoscopy as well as factors influencing 
it were identified.  
The willingness to participate in screening could be affected by awareness of 
stool examination and knowledge of CRC among participants (Stokamer, 2005). 
Having good awareness and knowledge of CRC should increase the compliance to 
FOBT testing and colonoscopy. Some demographic factors were predicted to have 
significant associations with the participants’ awareness of stool examination and 
knowledge of CRC. Identification of demographic factors that were predictors of 
good knowledge of CRC and awareness of stool examination could assist healthcare 
 24 
planners in identifying priority areas to focus health education programme that in 
future would help ensure good compliance to screening activities. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Awareness of stool 
examination 
Knowledge of CRC 
Demographic factors : 
Age 
Gender 
Religion 
Education 
Income per month 
Family history of cancer 
Spoken language 
Ethnicity 
Occupation 
Marital status 
 
 
 
 
Screening of CRC 
Compliance to FOBT 
testing (Return +ve / -ve) 
r 
Compliance to Colonoscopy 
Reasons for 
not 
complying 
to FOBT 
testing will 
be 
identified 
Reasons for non-
compliance to 
colonoscopy  
will be identified 
Fig. 2.1  Conceptual framework 
